Evidence map›Paper›PMID 39017702›Full record

ArticleJournal of neurology2024

Prevalence and characteristics of vascular cognitive impairment in a European cohort of adult patients with Moyamoya angiopathy.

Marine Giroud, Lionel Calviere, Carla Machado, Sonia Reyes, Hélène Mirabel, Nicolas Raposo, Pierre Brandicourt, Alain Viguier, Jean-François Albucher, Fabrice Bonneville and 5 more

Abstract read
In one paragraph

Article in Journal of neurology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Marine GiroudNeurology Department, Toulouse University Hospital, Toulouse, France. giroud.m@chu-toulouse.fr.ORCID http://orcid.org/0000-0002-8058-424X
Lionel CalviereNeurology Department, Toulouse University Hospital, Toulouse, France.
Carla MachadoNeurology Department, Hospital Paris Lariboisière, Paris, France.
Sonia ReyesNeurology Department, Hospital Paris Lariboisière, Paris, France.
Hélène MirabelNeurology Department, Toulouse University Hospital, Toulouse, France.
Nicolas RaposoNeurology Department, Toulouse University Hospital, Toulouse, France.
Pierre BrandicourtNeurology Department, Toulouse University Hospital, Toulouse, France.
Alain ViguierNeurology Department, Toulouse University Hospital, Toulouse, France.
Jean-François AlbucherNeurology Department, Toulouse University Hospital, Toulouse, France.
Fabrice BonnevilleNeurology Department, Toulouse University Hospital, Toulouse, France.
Jean Marc OlivotNeurology Department, Toulouse University Hospital, Toulouse, France.
Patrice PéranToulouse NeuroImaging Center ToNIC, Toulouse University, Toulouse, France.
Jérémie ParienteNeurology Department, Toulouse University Hospital, Toulouse, France.
Dominique HervéNeurology Department, Hospital Paris Lariboisière, Paris, France.
Mélanie PlantonNeurology Department, Toulouse University Hospital, Toulouse, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMoyamoya angiopathy (MMA) is associated with a high risk of stroke, but it is also increasingly recognized as leading to cognitive impairment. The aim of this study was to determine the prevalence, nature, and severity of vascular cognitive impairment no dementia (VCIND) in adults with MMA and to identify clinical and imaging factors associated with VCIND.

methodsWe conducted a retrospective study of consecutive adult patients with MMA followed in two tertiary hospitals (Toulouse and Paris Lariboisiere). All patients underwent neuropsychological assessment and brain magnetic resonance imaging (MRI). VCIND was defined as at least two variables of the same cognitive process with z-scores of < 2 standard deviations, regardless of the cognitive domain, that do not interfere in everyday life. Baseline demographic, clinical, and imaging data were compared between patients with and without VCIND.

resultsA total of 102 patients (mean age 43 years; 65% women) were included. Thirty-four patients (33.3%) had VCIND. VCIND was mild in 20/34 (59%), moderate in 8/34 (23%), and severe in 6/34 (18%) patients. Executive function was the most widely affected (25.5%), followed by attention and processing speed (24.8%). In univariable analyses, VCIND was associated with ischemic stroke at diagnosis and the presence of ischemic lesions on MRI.

conclusionsVCIND is highly prevalent in adults with MMA. Executive functions and processing speed are predominantly affected. These findings may guide clinicians in their evaluation of patients with MMA. Further research should assess the effect of revascularization therapies on cognitive functions.

Indexed as

Cognitive DysfunctionMoyamoya DiseaseAdultCohort StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsPrevalenceRetrospective StudiesMoyamoyaNeuropsychologyStrokeVascular cognitive disorders

Identifiers

PMID39017702
PMCPMC11377615

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.